Latest Barramundi (NZX:BRM) News

Barramundi Limited outperformed the S&P/ASX200 in April with a 4.4% gross return, boosted by NEXT DC’s landmark data centre deal and capital raise, while healthcare stocks faced headwinds from Cochlear’s profit downgrade.

Payments and fintech names drove the biggest swings this week, while the major banks leaned on profit growth, asset sales and capital management. Investors also had to weigh cyber risk, legal penalties and weaker portfolio values as global tensions stayed in the background.

Barramundi Limited’s portfolio took a heavy hit in Q1 2026, with a 15.4% adjusted NAV decline amid AI disruption anxieties and geopolitical tensions. The fund responded by trimming tech holdings and adding miners BHP and Rio Tinto, betting on copper demand and scale advantages.